Please login to the form below

Not currently logged in
Email:
Password:

Novartis’ Nicola Redfern joins Celgene to head UK market access

Role will focus on ensuring stakeholders keep receiving relevant product information as the NHS undergoes reforms

Nicola Redfern - CelgeneNicola Redfern has been appointed director of market access at Celgene for the UK and Ireland.

Redfern joins Celgene from Novartis where she was director of communications and external affairs for the Swiss pharma firm's oncology business unit.

At Novartis, she was responsible for health economics and outcomes research, communications, patient advocacy, government affairs and leadership of the field-based NHS development team, and Redfern will fill a similar role at Celgene focusing on the changing NHS landscape.

“I am very excited to join Celgene and bring my experience to the market access team to help continue the great work Celgene has been undertaking to improve patient outcome,” she said.

“There is a true need for new innovative medicines and I look forward to working with the team towards helping more patients receive access to these important treatments.”

Prior to joining Novartis in 2003, Redfern spent four years at Sanofi. This included spells as senior product manager and head of medical education. She has also worked in sales for MSD, Procter & Gamble and Pierre Fabrine.

Samantha Pearce, general manager of Celgene UK and Ireland, said: “We are delighted to welcome Nicola to our growing team at Celgene. Her role reinforces our continued commitment to making our treatments available and accessible to all that need them, particularly given the evolving policy environment.”

18th June 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...